Efficacy Study of Light Therapy as an Adjunctive Treatment for Parkinson's Disease Trial N/A Completed Oct. 22, 2018
Long- Term Transcranial Direct Current Stimulation in Parkinson's Disease Trial Phase 2 Unknown Oct. 18, 2018
Bioavailability and Bioequivalence Study of Two Different Sources of Opicapone Trial Phase 1 Completed Oct. 14, 2018
Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS) Trial Phase 2 Completed Oct. 10, 2018
Investigating the Microstructural and Functional Alterations of Brain in Parkinson's Disease Patients Trial Phase 2 Completed Oct. 9, 2018
Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson&Apos;s Disease Trial Phase 4 Terminated Oct. 8, 2018
Varenicline Treatment for Excessive Daytime Sleepiness in Parkinson's Disease Trial Phase 4 Terminated Oct. 8, 2018
Evaluation of the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes Trial Phase 3 Terminated Oct. 4, 2018
Developing a Novel Imaging Biomarker in the Differential Diagnosis of Parkinson's Disease and Parkinsonism Trial Phase 2 Completed Oct. 2, 2018
Impact of Non-traditional Guitar Group Instruction on Functional Movement and Well-being in Parkinson's Disease Patients Trial N/A Completed Oct. 1, 2018
A Study to Assess Pharmacokinetics (PK) of Preladenant in Participants With Chronic Renal Impairment (CRI) (P06512) Trial Phase 1 Completed Oct. 1, 2018
A Responsive Closed-Loop Approach to Treat Freezing of Gait in Parkinson's Disease Trial N/A Completed Sept. 27, 2018
Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD) Trial Phase 2 Completed Sept. 26, 2018
Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases. Trial N/A Completed Sept. 25, 2018
A Study of Movement Disorders Using the QMAT At-Home Testing Device Trial N/A Terminated Sept. 24, 2018